Silvia Heltai
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL.
Journal: American journal of hematology
Published: October 05, 2023
Relevance of Minimal Residual Disease in the Era of Targeted Agents.
Journal: Cancer journal (Sudbury, Mass.)
Published: November 26, 2019
The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer.
Journal: Journal for immunotherapy of cancer
Published: September 28, 2018
Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma.
Journal: Frontiers in immunology
Published: September 21, 2018
Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients.
Journal: Cancer research
Published: July 09, 2015
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.
Journal: Oncoimmunology
Published: December 01, 2014
Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.
Journal: Journal of translational medicine
Published: August 16, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026